These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 24759126)

  • 1. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
    Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC
    J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chang YY; Tsai CH; Peng SY; Chen ZW; Chang CC; Lee BC; Liao CW; Pan CT; Chen YL; Lin LC; Chang YR; Peng KY; Chou CH; Wu VC; Hung CS; Lin YH;
    Hypertension; 2021 Jan; 77(1):114-125. PubMed ID: 33249859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
    Seccia TM; Mantero F; Letizia C; Kuppusamy M; Caroccia B; Barisa M; Cicala MV; Miotto D; Rossi GP
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2307-13. PubMed ID: 23012392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
    Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T
    J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.
    Kitamoto T; Suematsu S; Matsuzawa Y; Saito J; Omura M; Nishikawa T
    J Atheroscler Thromb; 2015; 22(2):191-200. PubMed ID: 25253161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Meta-Analysis of Somatic KCNJ5 K(+) Channel Mutations In 1636 Patients With an Aldosterone-Producing Adenoma.
    Lenzini L; Rossitto G; Maiolino G; Letizia C; Funder JW; Rossi GP
    J Clin Endocrinol Metab; 2015 Aug; 100(8):E1089-95. PubMed ID: 26066531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
    Ip JC; Pang TC; Pon CK; Zhao JT; Sywak MS; Gill AJ; Soon PS; Sidhu SB
    ANZ J Surg; 2015 Apr; 85(4):279-83. PubMed ID: 24274318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCNJ5 Somatic Mutation Is a Predictor of Hypertension Remission After Adrenalectomy for Unilateral Primary Aldosteronism.
    Vilela LAP; Rassi-Cruz M; Guimaraes AG; Moises CCS; Freitas TC; Alencar NP; Petenuci J; Goldbaum TS; Maciel AAW; Pereira MAA; Silva GV; Pio-Abreu A; Zerbini MCN; Cavalcante ACBS; Carnevale FC; Pilan B; Yamauchi F; Srougi V; Tanno FY; Chambo JL; Latronico AC; Mendonca BB; Fragoso MCBV; Bortolotto LA; Drager LF; Almeida MQ
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4695-4702. PubMed ID: 31216002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
    Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
    Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and metabolic characters of
    Chang YY; Lee BC; Chen ZW; Tsai CH; Chang CC; Liao CW; Pan CT; Peng KY; Chou CH; Lu CC; Wu VC; Hung CS; Lin YH;
    Front Endocrinol (Lausanne); 2023; 14():1061704. PubMed ID: 36950676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary aldosteronism caused by a pI157S somatic
    Gomez-Sanchez CE; van Rooyen D; Rainey WE; Nanba K; Blinder AR; Baliga R
    Front Endocrinol (Lausanne); 2022; 13():921449. PubMed ID: 36051386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCNJ5 Somatic Mutation Is Associated With Higher Aortic Wall Thickness and Less Calcification in Patients With Aldosterone-Producing Adenoma.
    Lee BC; Kang VJ; Pan CT; Huang JZ; Lin YL; Chang YY; Tsai CH; Chou CH; Chen ZW; Liao CW; Chiu YW; Wu VC; Hung CS; Chang CC; Lin YH
    Front Endocrinol (Lausanne); 2022; 13():830130. PubMed ID: 35311227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
    Boulkroun S; Beuschlein F; Rossi GP; Golib-Dzib JF; Fischer E; Amar L; Mulatero P; Samson-Couterie B; Hahner S; Quinkler M; Fallo F; Letizia C; Allolio B; Ceolotto G; Cicala MV; Lang K; Lefebvre H; Lenzini L; Maniero C; Monticone S; Perrocheau M; Pilon C; Plouin PF; Rayes N; Seccia TM; Veglio F; Williams TA; Zinnamosca L; Mantero F; Benecke A; Jeunemaitre X; Reincke M; Zennaro MC
    Hypertension; 2012 Mar; 59(3):592-8. PubMed ID: 22275527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
    Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
    Oßwald A; Fischer E; Degenhart C; Quinkler M; Bidlingmaier M; Pallauf A; Lang K; Mussack T; Hallfeldt K; Beuschlein F; Reincke M
    Eur J Endocrinol; 2013 Nov; 169(5):657-63. PubMed ID: 23946277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI; Lifton RP
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling.
    Boulkroun S; Golib Dzib JF; Samson-Couterie B; Rosa FL; Rickard AJ; Meatchi T; Amar L; Benecke A; Zennaro MC
    Mol Cell Endocrinol; 2013 May; 371(1-2):221-7. PubMed ID: 23376008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of Aldosterone-Producing Adenoma in Korean Patients.
    Hong AR; Kim JH; Song YS; Lee KE; Seo SH; Seong MW; Shin CS; Kim SW; Kim SY
    PLoS One; 2016; 11(1):e0147590. PubMed ID: 26807823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.